One month post-dose 3 , for each of the vaccine pneumococcal serotypes , e `` 90.1 % of PHiD-CV recipients had an antibody concentration e `` 0.2 ug/mL compared to < 9 % ( except for serotypes 14 [ 32.4 % ] and 19F [ 27.8 % ] ) in the control group .